Clinical Trials Search Results

Showing 1-10 of 18

Sorted By:

  • Biohelix

    Participation Details: •30-day clinic visit •9-month clinic visit •Telephone follow-ups at 1 year, 2 years and 3 years

  • Breast Cancer - DFCI 06-169

    The Young Women's Breast Cancer Study

  • Breast Cancer - SWOG 1007

    For patients with 1-3 positive nodes, hormone receptor positive and HER2 negative breast cancer with recurrence score (RS) of 25 or less.

  • Chocolate BAR

    • Standard of care clinic visits and ultrasounds

  • Endomax

    •Laboratory testing while in hospital •30 day clinic visit with laboratory testing •Telephone follow-up at 1 year

  • Exscel

    •Clinic visits during screening, randomization, week 1 and month 2 & every 6 months •Laboratory assessments at visits •participation is between 3 and 5 years

  • Multiple Myeloma Connect MM

    To help establish which treatments are effective in the treatment of Multiple Myeloma. This is a data registry and not a clinical trial that requires specific treatment regimes.

  • Multiple Myeloma DFCI 08-273

    Phase II trial of combination Plerixafor (AMD3100), Bortezomib & Dexamethasone in relapsed or relapsed/refractory multiple myeloma.

  • Multiple Myeloma DFCI 10-106

    Comparing conventional dose treatment using lenalidomide, bortezomib and dexamethasone (RVD) to high dose treatment with peripheral stem cell transplant.

  • Multiple Myeloma DFCI 12-498

    A Phase II study of modified Lenalidomide, Bortezomib and Dexamethasone for transplant ineligible patients with newly diagnosed multiple myeloma.

Page of 2, showing trials 1-10 of 18

Contact Us

Cape Cod Hospital
27 Park Street
Hyannis MA 02601
Phone: 508-771-1800

Falmouth Hospital
100 Ter Heun Drive
Falmouth, MA 02540
Phone: 508-548-5300